EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimizing gRNA selection for high-penetrance F0 CRISPR screening for interrogating disease gene function

Sheng-Jia Lin iD, Kevin Huang iD, Cassidy Petree iD, Wei Qin iD, Pratishtha Varshney iD, Gaurav K Varshney iD

Nucleic Acids Research · 27.02.2025 · 53 (5)

DOI: 10.1093/nar/gkaf180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.03.2025. Verfasst von Sheng-Jia Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, United States. Hauptthemen laut MEDLINE: Penetrance, CRISPR-Cas Systems, RNA, Guide, CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCD NIH HHS, NIH HHS, US National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genes and genetic variants associated with human disease are continually being discovered, but validating their causative roles and mechanisms remains a significant challenge. CRISPR/Cas9 genome editing in model organisms like zebrafish can enable phenotypic characterization of founder generation (F0) knockouts (Crispants), but existing approaches are not amenable to high-throughput genetic screening due to high variability, cost, and low phenotype penetrance. To overcome these challenges, here we provide guide RNA (gRNA) selection rules that enable high phenotypic penetrance of up to three simultaneous knockouts in F0 animals following injection of 1–2 gRNAs per gene. We demonstrate a strong transcriptomic overlap in our F0 knockouts and stable knockout lines that take several months to generate. We systematically evaluated this approach across 324 gRNAs targeting 125 genes and demonstrated its utility in studying epistasis, characterizing paralogous genes, and validating human disease gene phenotypes across multiple tissues. Applying our approach in a high-throughput manner, we screened and identified 10 novel neurodevelopmental disorders and 50 hearing genes not previously studied in zebrafish. Altogether, our approach achieves high phenotypic penetrance using low numbers of gRNAs per gene in F0 zebrafish, offering a robust pipeline for rapidly characterizing candidate human disease genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PenetranceCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsGene EditingGenetic TestingAnimalsZebrafishHumansGene Knockout TechniquesPhenotypeEpistasis, Genetic

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Genes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, United States.

ORCID-Profile: Sheng-Jia Lin, Kevin Huang, Cassidy Petree, Wei Qin, Pratishtha Varshney, Gaurav K Varshney

Förderung

  • NIDCD NIH HHS
  • NIH HHS
  • US National Institutes of Health
  • Oklahoma Medical Research Foundation

Zitieren

APA

Lin, S. J., Huang, K., Petree, C., Qin, W., Varshney, P., & Varshney, G. K. (2025). Optimizing gRNA selection for high-penetrance F0 CRISPR screening for interrogating disease gene function. Nucleic Acids Research, 53(5). https://doi.org/10.1093/nar/gkaf180

Vancouver

Lin SJ, Huang K, Petree C, Qin W, Varshney P, Varshney GK. Optimizing gRNA selection for high-penetrance F0 CRISPR screening for interrogating disease gene function. Nucleic Acids Research. 2025;53(5). doi:10.1093/nar/gkaf180

BibTeX
@article{Lin2025,
  author = {Lin, Sheng-Jia and Huang, Kevin and Petree, Cassidy and Qin, Wei and Varshney, Pratishtha and Varshney, Gaurav K},
  title = {Optimizing gRNA selection for high-penetrance F0 CRISPR screening for interrogating disease gene function},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {5},
  doi = {10.1093/nar/gkaf180}
}
Kostenlos starten →